Structural heart devices market seen reaching $17.23 billion by 2030

The structural heart devices market is projected to grow from $11.37 billion in 2025 to $17.23 billion by 2030, driven by rising cardiovascular disease, broader use of minimally invasive procedures, and continued investment in cardiac technology. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Structural heart devices are used to repair or replace damaged valves and other heart structures, giving patients less invasive treatment options than open surgery. - Demand is rising as cardiovascular disease rates climb worldwide and healthcare systems expand access to specialized cardiac care. - The market’s projected move from $12.48 billion in 2026 to $17.23 billion by 2030 signals sustained demand for valve replacement, catheter-based delivery and imaging-guided procedures.

What happened: - The Business Research Company released its Structural Heart Devices Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report says the structural heart devices market will grow from $11.37 billion in 2025 to $12.48 billion in 2026. - The report forecasts the market will reach $17.23 billion by 2030, reflecting an 8.4% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing regional market in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available as a sample report. - The full report is available as the market report.

The details: - The market’s historic growth is tied to rising structural heart conditions, an aging global population, early adoption of valve replacement technologies, growth in specialized cardiac centers and advances in interventional cardiology. - Future growth is linked to preference for minimally invasive procedures, higher investment in cardiovascular innovation, expansion of pediatric cardiac interventions, wider use of AI-assisted diagnostics and demand for durable implants. - Expected market trends through 2030 include more transcatheter heart valve procedures, broader adoption of minimally invasive cardiac implants, more advanced imaging and navigation systems, catheter-based delivery technologies and patient-specific device designs. - Structural heart devices are specialized implants and instruments used to treat defects or abnormalities in the heart’s anatomy. - The devices repair or replace damaged heart components such as valves and septa and help restore normal cardiac function. - The devices are used to manage structural heart disease with less invasive treatment options than traditional surgery. - Cardiovascular disease remains a major driver of demand because it includes coronary artery disease, heart attacks, strokes and related disorders. - The report cites January 2024 American Heart Association data showing the age-adjusted US cardiovascular death rate rose to 233.3 per 100,000 people from 224.4 in 2023, a 4.0% increase. - The report says North America’s leadership reflects advanced healthcare infrastructure, high spending and strong adoption of new technologies. - The report says Asia-Pacific growth is being driven by rising healthcare investment, a large patient pool, greater awareness and expanding cardiac care facilities.

Between the lines: - The forecast points to a market shifting from basic device adoption toward more personalized, imaging-led and catheter-delivered therapies. - AI-assisted diagnostics and patient-specific design suggest competition is moving beyond hardware alone toward integrated treatment workflows. - Faster growth in Asia-Pacific indicates the next phase of demand may come from market expansion and care access, not only from technology upgrades in mature regions.

What's next: - The report expects growth to continue through 2030 as hospitals and cardiac centers expand minimally invasive treatment options. - The company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspots infographics and updated trend analysis. - The Business Research Company invites readers to request a sample report or review the full market report.

The bottom line: - Structural heart devices are moving deeper into mainstream cardiovascular care, and the market outlook remains strong as demand shifts toward less invasive, more precise treatment options.